Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study

BackgroundIn the United States, methamphetamine-related overdoses have tripled from 2015 to 2020 and continue to rise. However, efficacious treatments such as contingency management (CM) are often unavailable in health systems. ObjectiveWe conducted a single-arm p...

Full description

Bibliographic Details
Main Authors: Kevin A Hallgren, Mark H Duncan, Matthew D Iles-Shih, Eliza B Cohn, Connor J McCabe, Yanni M Chang, Andrew J Saxon
Format: Article
Language:English
Published: JMIR Publications 2023-07-01
Series:JMIR Formative Research
Online Access:https://formative.jmir.org/2023/1/e47516
_version_ 1797734033614962688
author Kevin A Hallgren
Mark H Duncan
Matthew D Iles-Shih
Eliza B Cohn
Connor J McCabe
Yanni M Chang
Andrew J Saxon
author_facet Kevin A Hallgren
Mark H Duncan
Matthew D Iles-Shih
Eliza B Cohn
Connor J McCabe
Yanni M Chang
Andrew J Saxon
author_sort Kevin A Hallgren
collection DOAJ
description BackgroundIn the United States, methamphetamine-related overdoses have tripled from 2015 to 2020 and continue to rise. However, efficacious treatments such as contingency management (CM) are often unavailable in health systems. ObjectiveWe conducted a single-arm pilot study to evaluate the feasibility, engagement, and usability of a fully remotely delivered mobile health CM program offered to adult outpatients who used methamphetamine and were receiving health care within a large university health system. MethodsParticipants were referred by primary care or behavioral health clinicians between September 2021 and July 2022. Eligibility criteria screening was conducted by telephone and included self-reported methamphetamine use on ≥5 out of the past 30 days and a goal of reducing or abstaining from methamphetamine use. Eligible participants who agreed to take part then completed an initial welcome phase that included 2 videoconference calls to register for and learn about the CM program and 2 “practice” saliva-based substance tests prompted by a smartphone app. Participants who completed these welcome phase activities could then receive the remotely delivered CM intervention for 12 consecutive weeks. The intervention included approximately 24 randomly scheduled smartphone alerts requesting a video recording of themselves taking a saliva-based substance test to verify recent methamphetamine abstinence, 12 weekly calls with a CM guide, 35 self-paced cognitive behavioral therapy modules, and multiple surveys. Financial incentives were disbursed via reloadable debit cards. An intervention usability questionnaire was completed at the midpoint. ResultsOverall, 37 patients completed telephone screenings, with 28 (76%) meeting the eligibility criteria and consenting to participate. Most participants who completed a baseline questionnaire (21/24, 88%) self-reported symptoms consistent with severe methamphetamine use disorder, and most had other co-occurring non-methamphetamine substance use disorders (22/28, 79%) and co-occurring mental health disorders (25/28, 89%) according to existing electronic health records. Overall, 54% (15/28) of participants successfully completed the welcome phase and were able to receive the CM intervention. Among these participants, engagement with substance testing, calls with CM guides, and cognitive behavioral therapy modules varied. Rates of verified methamphetamine abstinence in substance testing were generally low but varied considerably across participants. Participants reported positive opinions about the intervention’s ease of use and satisfaction with the intervention. ConclusionsFully remote CM can be feasibly delivered within health care settings lacking existing CM programs. Although remote delivery may help reduce barriers to treatment access, many patients who use methamphetamine may struggle to engage with initial onboarding. High rates of co-occurring psychiatric conditions in the patient population may also contribute to uptake and engagement challenges. Future efforts could leverage greater human-to-human connection, more streamlined onboarding procedures, larger incentives, longer durations, and the incentivization of non–abstinence-based recovery goals to increase uptake and engagement with fully remote mobile health–based CM.
first_indexed 2024-03-12T12:38:24Z
format Article
id doaj.art-6ebc84c56ee74e4782693fbf5f36c53f
institution Directory Open Access Journal
issn 2561-326X
language English
last_indexed 2024-03-12T12:38:24Z
publishDate 2023-07-01
publisher JMIR Publications
record_format Article
series JMIR Formative Research
spelling doaj.art-6ebc84c56ee74e4782693fbf5f36c53f2023-08-29T00:01:39ZengJMIR PublicationsJMIR Formative Research2561-326X2023-07-017e4751610.2196/47516Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot StudyKevin A Hallgrenhttps://orcid.org/0000-0001-8386-3984Mark H Duncanhttps://orcid.org/0000-0003-2810-7304Matthew D Iles-Shihhttps://orcid.org/0009-0003-6422-7562Eliza B Cohnhttps://orcid.org/0009-0006-8494-7593Connor J McCabehttps://orcid.org/0000-0003-1868-8459Yanni M Changhttps://orcid.org/0000-0001-6750-9985Andrew J Saxonhttps://orcid.org/0000-0003-3880-2589 BackgroundIn the United States, methamphetamine-related overdoses have tripled from 2015 to 2020 and continue to rise. However, efficacious treatments such as contingency management (CM) are often unavailable in health systems. ObjectiveWe conducted a single-arm pilot study to evaluate the feasibility, engagement, and usability of a fully remotely delivered mobile health CM program offered to adult outpatients who used methamphetamine and were receiving health care within a large university health system. MethodsParticipants were referred by primary care or behavioral health clinicians between September 2021 and July 2022. Eligibility criteria screening was conducted by telephone and included self-reported methamphetamine use on ≥5 out of the past 30 days and a goal of reducing or abstaining from methamphetamine use. Eligible participants who agreed to take part then completed an initial welcome phase that included 2 videoconference calls to register for and learn about the CM program and 2 “practice” saliva-based substance tests prompted by a smartphone app. Participants who completed these welcome phase activities could then receive the remotely delivered CM intervention for 12 consecutive weeks. The intervention included approximately 24 randomly scheduled smartphone alerts requesting a video recording of themselves taking a saliva-based substance test to verify recent methamphetamine abstinence, 12 weekly calls with a CM guide, 35 self-paced cognitive behavioral therapy modules, and multiple surveys. Financial incentives were disbursed via reloadable debit cards. An intervention usability questionnaire was completed at the midpoint. ResultsOverall, 37 patients completed telephone screenings, with 28 (76%) meeting the eligibility criteria and consenting to participate. Most participants who completed a baseline questionnaire (21/24, 88%) self-reported symptoms consistent with severe methamphetamine use disorder, and most had other co-occurring non-methamphetamine substance use disorders (22/28, 79%) and co-occurring mental health disorders (25/28, 89%) according to existing electronic health records. Overall, 54% (15/28) of participants successfully completed the welcome phase and were able to receive the CM intervention. Among these participants, engagement with substance testing, calls with CM guides, and cognitive behavioral therapy modules varied. Rates of verified methamphetamine abstinence in substance testing were generally low but varied considerably across participants. Participants reported positive opinions about the intervention’s ease of use and satisfaction with the intervention. ConclusionsFully remote CM can be feasibly delivered within health care settings lacking existing CM programs. Although remote delivery may help reduce barriers to treatment access, many patients who use methamphetamine may struggle to engage with initial onboarding. High rates of co-occurring psychiatric conditions in the patient population may also contribute to uptake and engagement challenges. Future efforts could leverage greater human-to-human connection, more streamlined onboarding procedures, larger incentives, longer durations, and the incentivization of non–abstinence-based recovery goals to increase uptake and engagement with fully remote mobile health–based CM.https://formative.jmir.org/2023/1/e47516
spellingShingle Kevin A Hallgren
Mark H Duncan
Matthew D Iles-Shih
Eliza B Cohn
Connor J McCabe
Yanni M Chang
Andrew J Saxon
Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study
JMIR Formative Research
title Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study
title_full Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study
title_fullStr Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study
title_full_unstemmed Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study
title_short Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study
title_sort feasibility engagement and usability of a remote smartphone based contingency management program as a treatment add on for patients who use methamphetamine single arm pilot study
url https://formative.jmir.org/2023/1/e47516
work_keys_str_mv AT kevinahallgren feasibilityengagementandusabilityofaremotesmartphonebasedcontingencymanagementprogramasatreatmentaddonforpatientswhousemethamphetaminesinglearmpilotstudy
AT markhduncan feasibilityengagementandusabilityofaremotesmartphonebasedcontingencymanagementprogramasatreatmentaddonforpatientswhousemethamphetaminesinglearmpilotstudy
AT matthewdilesshih feasibilityengagementandusabilityofaremotesmartphonebasedcontingencymanagementprogramasatreatmentaddonforpatientswhousemethamphetaminesinglearmpilotstudy
AT elizabcohn feasibilityengagementandusabilityofaremotesmartphonebasedcontingencymanagementprogramasatreatmentaddonforpatientswhousemethamphetaminesinglearmpilotstudy
AT connorjmccabe feasibilityengagementandusabilityofaremotesmartphonebasedcontingencymanagementprogramasatreatmentaddonforpatientswhousemethamphetaminesinglearmpilotstudy
AT yannimchang feasibilityengagementandusabilityofaremotesmartphonebasedcontingencymanagementprogramasatreatmentaddonforpatientswhousemethamphetaminesinglearmpilotstudy
AT andrewjsaxon feasibilityengagementandusabilityofaremotesmartphonebasedcontingencymanagementprogramasatreatmentaddonforpatientswhousemethamphetaminesinglearmpilotstudy